Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02968355 · ClinicalTrials.gov registry record

Clinical Evaluation of the FilmArray® Global Fever (GF) Panel

A clinical trial of Fever, sponsored by BioFire Defense.

Completed
Registry status
2,084
Enrollment target
11
Study locations

NCT02968355 is a study of Fever that has completed, run by BioFire Defense. The registered enrollment target is 2,084 participants, above the 484-participant average among 18 other Fever trials with a reported enrollment target (331% higher). The trial reports 11 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02968355, a study of Fever, has completed, sponsored by BioFire Defense.

COMPLETED
Registry status
2,084 participants
Enrollment target
11
Study locations

Study Summary

This study will evaluate the clinical sensitivity and specificity of the FilmArray Global Fever (GF) Panel.

Conditions Studied

Interventions

  • OTHER Observational study

Study Locations (11)

Other

  • Naval Medical Research Unit Two - Phnom Penh
  • United States Army Medical Research Directorate Georgia - Tbilisi
  • Naval Medical Research Unit Three - Navrongo
  • United States Army Medical Research Directorate Kenya - Kisumu
  • Naval Medical Research Unit Six - Iquitos
  • Kilimanjaro Christian Medical Centre - Moshi
  • Armed Forces Research Institute of Medical Sciences - Bangkok
  • Infectious Diseases Institute - Kampala

District of Columbia

  • George Washington University - Washington D.C.

Missouri

  • Washington University - St Louis

Central District

  • Universidad Nacional Autonoma de Honduras - Tegucigalpa

Trial Details

FieldValue
Enrollment Target 2,084 participants
Start Date 2018-03-26
Est. Completion 2021-03-30

Sponsor

BioFire Defense

2 total trials

What the Registry Record Tells You About NCT02968355

The ClinicalTrials.gov registry entry for NCT02968355 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,084 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 484-participant average among 18 other Fever trials with a reported enrollment target (331% higher). The listed sponsor is BioFire Defense, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Fever appearing as the primary indexed condition, and to 1 intervention - of which Observational study is the first listed.

NCT02968355 reports 11 study locations spanning 4 distinct geographic areas - top geographies include Other, District of Columbia, Missouri.

Frequently Asked Questions

What is clinical trial NCT02968355 about?

NCT02968355 is a clinical study titled "Clinical Evaluation of the FilmArray® Global Fever (GF) Panel". This study will evaluate the clinical sensitivity and specificity of the FilmArray Global Fever (GF) Panel.

What is the current status of trial NCT02968355?

This trial is currently completed. The enrollment target is 2,084 participants. The study started on 2018-03-26. Estimated completion is 2021-03-30.

What conditions does trial NCT02968355 study?

This clinical trial studies the following conditions: Fever.

What interventions are being tested in trial NCT02968355?

The interventions under investigation include: Observational study (OTHER).

Who is sponsoring clinical trial NCT02968355?

This trial is sponsored by BioFire Defense, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02968355 being conducted?

This trial has 11 study locations across District of Columbia, Missouri, Central District. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fever

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.